We’re Making Moves To Serve You Better
YMC America just completed the combination and expansion of our US operations at our YMC campus in Devens, MA.
This puts our columns and stationary phase team under the same roof (actually, several roofs) with the research, design, and manufacturing teams of our large-scale purification systems.
What does this mean for you?
Our bigger facility means more inventory, better service, and expanded resources. The new facility complies with ISO 9001:2015 guidelines.
We are also expanding our laboratory services to include more testing, training, and support, with new labs in Devens and Thousand Oaks, CA.
Read the complete announcement about our recent moves here.
Previous Article
YMC Scale Up Platform Product Array Related Posts
![](https://www.ymcamerica.com/wp-content/uploads/2023/02/YMC-Training-in-Devens-2023-e1676499958685.jpg)
February 16, 2023
One YMC
YMC America recently hosted colleagues from Japan for a two-week training on YMC’s patented process scale Contichrom TWIN MCSGP technology to support the growing demand in Asia. We may live on different continents, but we are one YMC family!
![Multicolumn Countercurrent Solvent Gradient Purification Process To Be Discussed By YMC at the World Biopharma Forum 2022](https://www.ymcamerica.com/wp-content/uploads/2024/02/YMC-America-logo-2-1-482x220.png)
March 23, 2022
Multicolumn Countercurrent Solvent Gradient Purification Process To Be Discussed By YMC at the World Biopharma Forum 2022
History shows that uptake of innovation is metered in the biopharma industry, but if the invention has checked all the “user need” boxes, its acceptance has an inflection point. This inflection point, when graphed, resembles a hockey stick (hopefully pointing
![YMC’s BioPro is a Reliable Tool for Analyzing PEGylated Proteins](https://www.ymcamerica.com/wp-content/uploads/2024/02/YMC-America-logo-2-1-482x220.png)
January 15, 2022
YMC’s BioPro is a Reliable Tool for Analyzing PEGylated Proteins
Ligand® Pharmaceuticals Inc. had an excellent success utilizing YMC’s BioProIEX to analyze PEGylated protein charge variants reproducibly. They developed a characterization method for PEGylated biotherapeutic proteins that can provide increased information without compromising peak shape and resolution and wanted to